Industry Insights
Latest in gene therapy and rare disease
BioSpace
CAR T for autoimmune disease benefits from oncology’s lessons—and will deliver its own
Thanks in part to the revolution cell therapy brought to treating blood cancers, the modality is now showing promise in some autoimmune applications. This expansion is poised to yield even wider benef
GEN News
CAR T-Cell Therapy Puts Severe Rheumatoid Arthritis Into Remission in First Clinical Trial
Researchers at Charité report promising results from the first CAR T-cell trial for treatment-refractory rheumatoid arthritis, with all six patients improving and three achieving sustained medication-